As of March 23, 2026, Evolus's top three insider holders are Inc. Medytox (Other, 3.38Mn shares), Vikram Malik (Director, 1.14Mn shares), David Moatazedi (See Remarks, 667.60K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Inc. Medytox | 3,381,326 | 0 | 18 Oct, 2023 | |
| Vikram Malik | 0 | 1,143,701 | 25 Aug, 2021 | |
| David Moatazedi | See Remarks | 604,700 | 0 | 20 Mar, 2026 |
| Rui Avelar | See Remarks | 427,423 | 0 | 20 Mar, 2026 |
| Vikram Malik | 321,109 | 0 | 19 Feb, 2026 | |
| Tatjana Mitchell | Chief Financial Officer | 226,092 | 0 | 19 Feb, 2026 |
| Lauren P Silvernail | See Remarks | 141,571 | 0 | 18 May, 2022 |
| Crystal Muilenburg | Chief Marketing Officer | 134,248 | 0 | 10 Mar, 2022 |
| Brady Stewart | 134,188 | 0 | 19 Feb, 2026 | |
| Albert G Iii White | 95,937 | 0 | 19 Feb, 2026 | |
| Tomoko Yamagishi-Dressler | Chief Marketing Officer | 89,949 | 0 | 26 Aug, 2025 |
| David N Gill | 86,887 | 0 | 19 Feb, 2026 | |
| Karah Herdman Parschauer | 77,742 | 0 | 19 Feb, 2026 | |
| Robert Hayman | 54,856 | 0 | 09 Feb, 2024 | |
| Peter C Farrell | 43,174 | 0 | 31 Jan, 2023 | |
| Robert Hayman | 0 | 10,366 | 15 Aug, 2023 | |
| Peter C Farrell | 0 | 10,000 | 06 Sep, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Mar, 2026 | Rui Avelar | Common Stock | D | 3,119 | $4.75 | 427,423 | D | S |
| 20 Mar, 2026 | David Moatazedi | Common Stock | D | 13,669 | $4.75 | 604,700 | D | S |
| 16 Mar, 2026 | David Moatazedi | Common Stock | A | 67,489 | $0.00 | 735,089 | D | M |
| 16 Mar, 2026 | Rui Avelar | Common Stock | A | 8,804 | $0.00 | 460,538 | D | M |
| 17 Mar, 2026 | David Moatazedi | Common Stock | D | 116,720 | $4.89 | 618,369 | D | S |
| 17 Mar, 2026 | Rui Avelar | Common Stock | D | 29,996 | $4.89 | 430,542 | D | S |
| 16 Mar, 2026 | David Moatazedi | Performance Restricted Stock Units | D | 67,489 | $0.00 | 67,488 | D | M |
| 16 Mar, 2026 | Rui Avelar | Performance Restricted Stock Units | D | 8,804 | $0.00 | 8,802 | D | M |
| 17 Feb, 2026 | Albert G Iii White | Common Stock | A | 45,559 | $0.00 | 95,937 | D | A |
| 17 Feb, 2026 | Karah Herdman Parschauer | Common Stock | A | 45,559 | $0.00 | 77,742 | D | A |
| 17 Feb, 2026 | Vikram Malik | Common Stock | A | 45,559 | $0.00 | 321,109 | D | A |
| 17 Feb, 2026 | David N Gill | Common Stock | A | 45,559 | $0.00 | 86,887 | D | A |
| 17 Feb, 2026 | Brady Stewart | Common Stock | A | 45,559 | $0.00 | 134,188 | D | A |
| 17 Feb, 2026 | Rui Avelar | Common Stock | A | 94,913 | $0.00 | 451,734 | D | A |
| 17 Feb, 2026 | David Moatazedi | Common Stock | A | 313,212 | $0.00 | 667,600 | D | A |
| 17 Feb, 2026 | Tatjana Mitchell | Common Stock | A | 121,489 | $0.00 | 226,092 | D | A |
| 17 Feb, 2026 | Rui Avelar | Performance Restricted Stock Units | A | 94,913 | $0.00 | 94,913 | D | A |
| 17 Feb, 2026 | Tatjana Mitchell | Performance Restricted Stock Units | A | 121,489 | $0.00 | 121,489 | D | A |
| 17 Feb, 2026 | David Moatazedi | Performance Restricted Stock Units | A | 626,424 | $0.00 | 626,424 | D | A |
| 17 Feb, 2026 | Rui Avelar | Stock Option (Right to Buy) | A | 138,649 | $0.00 | 138,649 | D | A |